News
The research could have far-reaching implications for the training of therapists and the delivery of psychedelic therapies in clinical settings
Hi, what are you looking for?
Mugglehead Investment Magazine
Psychedelics
News
When ingested, 1,4-butanediol produces an effect that is not unlike that of Gamma-Hydroxybutyrate (GHB)
News
Poor mental health affects not only quality of life but performance, resilience and career trajectories of athletes
Psychedelics
The clinical trials will examine the effects of the company's botanical psilocybin drug candidate PEX010
News
The model combines the use of a psychedelic medication with therapy in a single session
Psychedelics
CYB003 is a molecule developed by the company with rapid onset and a short duration
Psychedelics
The psychedelic drug developer says the new method increases potency while maintaining the mushroom's botanical qualities
News
The company announced the supply agreement last May
Psychedelics
The majority of participants reported significant improvements in their overall mental health
News
The MHRA has confirmed that PharmAla's MDMA-like drug candidate ALA-002 does not require additional preclinical data
